Pune: Now, Serum Institute of India (SII) wants to manufacture COVID-19 vaccine Sputnik V.
The Pune-based company has already applied to the Drugs Controller General of India (DCGI) seeking permission to make the Russian vaccine.
“Serum Institute of India (SII) put up an application to Drugs Controller General of India on Wednesday seeking permission to manufacture the COVID-19 vaccine, Sputnik V, in India,” PTI quoted a source as saying.
SII has also sought approval for test analysis and examination.
Also Read: Serum Institute Seeks Legal Shield Against Vaccine Side Effects
Sputnik V, which was given emergency use authorisation in April, is being produced in India by Dr Reddy’s Laboratories and five other companies.
Sputnik V has been rolled out in India with Russia supplying the vaccine in multiple consignments. On Tuesday, 30 lakh doses of Sputnik V arrived in Hyderabad.
SII will manufacture and supply 10 crore Covishield doses this month. It will also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.
Cuttack: A promising youthful life ended in Cuttack on Sunday as a sophomore was electrocuted…
Mumbai: Ever since ‘Kantara’ became a phenomenal hit in 2022, movie lovers have been yearning…
Bhubaneswar: The husband of a sarpanch and a panchayat samiti member were critically injured as…
New Delhi: Pollution in the national Capital is going from bad to worse. As Delhi’s air…
Bhubaneswar: In order to streamline the road construction works, the Odisha government is planning to…
Patna: The trailer of ‘Pushpa 2: The Rule’, one of the year’s most anticipated films, is…
Patna: It was one of the most anticipated events in the Indian film industry -- the…
Bhubaneswar: With Odisha government taking a serious note of unnatural death of elephants, the Forest…